Zydus Cadila gets USFDA approval for sales of hypertension drug

HOME » BUSINESS » HEALTHCARE » Zydus Cadila gets USFDA approval for sales of hypertension drug

Pharmaceutical manufacturer Zydus Cadila said it received the final approval for sales of a generic equivalent of Pfizer’s Thalitone tablets.

Chlorthalidone tablets are used for the treatment of high blood pressure or hypertension. It is also used to treat fluid retention or edema in people with congestive heart failure, cirrhosis of the liver or kidney disorders.

The pills, in doses of 25 mg and 50 mg, will be manufactured at Zydus’ manufacturing facility at Ahmedabad.

With the latest approval, Zydus has so far received 266 approvals and filed over 350 applications for sales of its generic drugs.

Headquartered in Ahmedabad, Zydus Cadila has manufacturing sites and research facilities across Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim and in the United States and Brazil.

(Now you can get topic-based alerts via WhatsApp)


Sign up to get the latest Pharma-related news delivered via email:

Don't forget to click on the activation link we send to your email